CELYAD ONCOLOGY Stock Went Down By Over 23% In The Last 10 Sessions
(VIANEWS) – Shares of CELYAD ONCOLOGY (BEL 20: CYAD.BR) fell by a staggering 23.53% in 10 sessions from €0.85 to €0.65 at 14:07 EST on Wednesday, after five successive sessions in a row of losses. BEL 20 is falling 0.3% to €3,819.64, following the last session’s downward trend. About CELYAD ONCOLOGY Celyad Oncology SA, a…